Overview

The traditional Chinese medicine rehabilitation for the deglutition and cognitive impairment after stroke will be intervened, which can promote the recovery of dysphagia and cognitive function of stroke patients, reduce the disability rate and improve the quality of life.

Eligibility

Inclusion Criteria:

• Dysphagia
• Meet the diagnostic criteria of stroke in traditional Chinese medicine;
• Meet the diagnostic criteria of ischemic stroke in western medicine;
• meet the diagnostic criteria of pseudobulbar palsy;
• Age is 18-85, gender not limited;
• The course of disease is 30 to 180 days;
• Water test level 3 and level 3 above;
• Meet the requirements for indications of acupuncture and moxibustion techniques; Volunteer to participate in this project, the patient has no serious complications, can accept acupuncture treatment and good compliance;
• Sign informed consent.
• Cognitive disorder
• Chinese medicine diagnosed as apoplexy;
• The diagnosis of cerebral infarction or cerebral hemorrhage was consistent with western medicine by CT/MRI examination;
• The course of disease ranges from 30 to 180 days;
• First onset; Or come on in the past without the sequela such as limb paralysis; Age 18 years;
• Informed consent signed by the legal guardian of the patient;
• Montreal cognitive assessment scale (Montreal Cognitive Assessment, MoCA) score reaches a certain standard, MoCA scale score of 30 points, scored 26 points or less judged with cognitive impairment, if the education time 12 years or less on the basis of plus 1;
• Hamilton depression scale (HAMD) < 20.
• Meet the requirements of indications of acupuncture and moxibustion; Volunteer to participate in this project, the patient has no serious complications, can accept acupuncture treatment and good compliance.

Exclusion Criteria:

• Dysphagia
• Patients with true bulbar palsy caused by brainstem encephalitis, motor neurone disease, pontine tumor, multiple sclerosis, myasthenia gravis, medulla bulbar cavity;
• Cerebral hemorrhage caused by cerebrovascular malformation, trauma, aneurysm and other causes;
• Pregnant or lactating women;
• Patients with severe primary chronic diseases, severe dementia and cognitive impairment, serious language understanding disorders, and mental illness, including heart, liver, kidney and other viscera, as well as the endocrine system and hematopoietic system;
• Suffered from a variety of bleeding tendency diseases;
• The patient to swallow contrast drug allergy;
• Patients who do not meet the inclusion criteria, do not have poor treatment compliance as prescribed, cannot judge the efficacy or incomplete data affect the judgment of efficacy and are not suitable for clinical observation;
• Cognitive disorder
• Subarachnoid hemorrhage, transient ischemic attack, or with other intracranial lesions such as intracranial tumor, aneurysm, vascular malformation, cysticercosis, schistosomiasis, encephalitis, meningitis, hydrocephalus, brain trauma sequelae; Non-atherosclerotic thrombotic cerebral infarction (such as cardiogenic embolism, clotting status, endovascular shedding, arteritis, etc.);
• Patients with severe primary chronic diseases such as heart, liver, kidney, viscera, endocrine system, hematopoietic system, serious disorders of language understanding, and mental disorders;
• Suffered from a variety of bleeding tendency diseases;
• Pregnant or lactating women;
• Patients who do not meet the inclusion criteria, do not have poor treatment compliance as prescribed, which cannot judge the efficacy or incomplete data affect the efficacy judgment and are not suitable for clinical observation; before the occurrence of the cerebrovascular accident, due to other reasons (such as surgery, trauma, congenital disability) lead to the existence of limb movement dysfunction of the patients.